Curiox Biosystems recorded one notable insider transaction over the past ninety days. Representative Director Nam Yong Kim executed a planned sale of 388,513 shares, totaling approximately 23 billion KRW. This divestment occurred amid a 38.1% increase in the company's stock price, though no recent earnings report provides further context regarding these specific equity movements.